uBiome Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Out of Business

  • Employees
  • 100

Employees

  • Latest Deal Type
  • Liquidation

uBiome General Information

Description

Provider of sequencing-based clinical microbiome tests designed to gather, analyze, and translate data about the human microbiome. The company combines precision sequencing with machine learning and artificial intelligence to advance the science of the microbiome and make it useful, enabling doctors to get the accurate and required result to treat their patients and patients to take greater and better care of their health.

Contact Information

Website
www.ubiome.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 360 Langton Street
  • San Francisco, CA 94103
  • United States
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 360 Langton Street
  • San Francisco, CA 94103
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

uBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Liquidation 01-Oct-2019 Completed Bankruptcy: Liquidation
10. Later Stage VC (Series C) 21-Sep-2018 Completed Generating Revenue
9. Early Stage VC (Series B) 29-Nov-2016 Completed Generating Revenue
8. Accelerator/Incubator 01-Jun-2015 Completed Startup
7. Product Crowdfunding 25-Apr-2015 Completed Startup
6. Accelerator/Incubator 19-Aug-2014 Completed Startup
5. Early Stage VC (Series A) 01-Jun-2014 Completed Startup
4. Seed Round 29-Oct-2013 Completed Startup
3. Product Crowdfunding 30-Sep-2013 $350K Completed Startup
2. Product Crowdfunding 19-Feb-2013 $361K Completed Startup
To view uBiome’s complete valuation and funding history, request access »

uBiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C3
Series C2
Series C1
Series B 17,565,505 $0.000100 $0.07 $1.14 $1.14 1x $1.14 19.18%
Series A 18,111,922 $0.000100 $0.02 $0.34 $0.34 1x $0.34 19.78%
To view uBiome’s complete cap table history, request access »

uBiome Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of sequencing-based clinical microbiome tests designed to gather, analyze, and translate data about the human m
Laboratory Services (Healthcare)
San Francisco, CA
100 As of 2019

Bellevue, WA
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

uBiome Competitors (5)

One of uBiome’s 5 competitors is Viome Life Sciences, a Venture Capital-Backed company based in Bellevue, WA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Viome Life Sciences Venture Capital-Backed Bellevue, WA
BiomeSense Venture Capital-Backed Chicago, IL
Quantbiome Venture Capital-Backed Nashville, TN
Vertero Therapeutics Venture Capital-Backed Woburn, MA
Everlywell Venture Capital-Backed Austin, TX
You’re viewing 5 of 5 competitors. Get the full list »

uBiome Patents

uBiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020131923-A1 Automatic standardization pipeline for data analysis Inactive 17-Dec-2018
WO-2019178610-A1 Method and system for characterization of metabolism-associated conditions, including diagnostics and therapies, based on bioinformatics approach Inactive 16-Mar-2018
WO-2019169395-A1 Method and system for high-throughput particle handling by use of magnetic fields and device Inactive 02-Mar-2018
WO-2019090353-A1 Control processes for microorganism-related characterization processes Inactive 06-Nov-2017
WO-2019074960-A1 Single molecule sequencing and unique molecular identifiers to characterize nucleic acid sequences Inactive 09-Oct-2017 C12Q1/6869
To view uBiome’s complete patent history, request access »

uBiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

uBiome FAQs

  • When was uBiome founded?

    uBiome was founded in 2012.

  • Where is uBiome headquartered?

    uBiome is headquartered in San Francisco, CA.

  • What is the size of uBiome?

    uBiome has 100 total employees.

  • What industry is uBiome in?

    uBiome’s primary industry is Laboratory Services (Healthcare).

  • Is uBiome a private or public company?

    uBiome is a Private company.

  • What is uBiome’s current revenue?

    The current revenue for uBiome is .

  • How much funding has uBiome raised over time?

    uBiome has raised $105M.

  • Who are uBiome’s competitors?

    Viome Life Sciences, BiomeSense, Quantbiome, Vertero Therapeutics, and Everlywell are competitors of uBiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process